We're raising our price target on Eli Lilly as the obesity-drug boom rolls on
Reported by CNBC — Top News.
This story is developing. Read the full report from CNBC — Top News.
Original reporting
This brief was written with AI assistance from the reports listed above and checked against our editorial policy. Spotted an error? Request a correction.
